Storer Ben, Kershaw Kelly Ann, Braund Taylor A, Chakouch Cassandra, Coleshill Matthew J, Haffar Sam, Harvey Samuel, Newby Jill M, Sicouri Gemma, Murphy Michael
The Black Dog Institute, Sydney, Australia.
The Black Dog Institute, Sydney, Australia; Psychiatry and Mental Health Department, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
Curr Probl Cardiol. 2023 Nov;48(11):101877. doi: 10.1016/j.cpcardiol.2023.101877. Epub 2023 Jun 17.
Anxiety and anxiety disorders are associated with adverse cardiovascular outcomes, and reduced quality of life. Despite this, no comprehensive study on the global prevalence of anxiety symptoms and disorders among adult cardiology outpatients exists. This systematic review and meta-analysis aims to provide cardiologists with a precise estimate of the prevalence of anxiety in their outpatient clinics. PubMed, Embase, Cochrane and PsycINFO databases and Google Scholar were searched from database inception to January 23, 2023. Data characteristics were extracted independently by 2 investigators. Ninety-three studies, n = 36,687 participants across 31 countries, were included. Global prevalence of anxiety symptoms/disorders was 28.9% (95%CI 25.7-32.4; 8927/36, 687; I2 = 97.33; n = 93). The highest rates were found in patients presenting with hypertension, 43.6%. Subgroup analyses revealed higher prevalence estimates when using self-report screening compared to gold-standard diagnostic interview. When using diagnostic interview, the highest rates were reported in outpatients with undifferentiated chest pain/palpitations, 19·0%. Panic disorder was the most frequent diagnosis 15.3%, and rates were significantly higher in patients with undifferentiated chest pain/palpitations compared to ischemic heart disease. Higher rates of anxiety were found in studies of outpatients from developing countries, and female outpatients tended to have higher rates compared to males. Anxiety occurred frequently among cardiology outpatients and at a higher rate than estimated in the general population. Given the impact anxiety has on patient outcomes, it is important that effective identification and management strategies be developed to support cardiologists in identifying and treating these conditions in their clinics.
焦虑及焦虑症与不良心血管结局及生活质量下降相关。尽管如此,目前尚无关于成年心脏病门诊患者中焦虑症状及障碍全球患病率的全面研究。本系统评价和荟萃分析旨在为心脏病专家提供其门诊中焦虑症患病率的精确估计。检索了PubMed、Embase、Cochrane和PsycINFO数据库以及谷歌学术,检索时间从数据库建立至2023年1月23日。由2名研究人员独立提取数据特征。纳入了93项研究,涉及31个国家的36,687名参与者。焦虑症状/障碍的全球患病率为28.9%(95%CI 25.7 - 32.4;8927/36,687;I² = 97.33;n = 93)。高血压患者中的患病率最高,为43.6%。亚组分析显示,与金标准诊断访谈相比,使用自我报告筛查时患病率估计值更高。使用诊断访谈时,未分化胸痛/心悸门诊患者的患病率最高,为19.0%。惊恐障碍是最常见诊断类型,为15.3%,与缺血性心脏病患者相比,未分化胸痛/心悸患者的患病率显著更高。在发展中国家门诊患者的研究中焦虑症患病率更高,女性门诊患者的患病率往往高于男性。焦虑症在心脏病门诊患者中很常见,且患病率高于一般人群中的估计值。鉴于焦虑对患者结局的影响,制定有效的识别和管理策略以支持心脏病专家在其诊所中识别和治疗这些病症非常重要。